Cell-matrix and cell-cell adhesive interactions play important roles in the normal organization and stabilization of the cell layer in epithelial tissue. Alterations in the expression and function of these adhesion systems that cause a switch to a migratory phenotype in tumor invasion and metastasis are critical for the malignant conversion of epithelial cells. Thymosin b-4 (Tb-4) is the major actinsequestering protein that has been shown to be upregulated in a wide variety of human carcinomas and has been implicated to be involved in altering the motility of certain tumors. We have recently demonstrated that the growth rate, colony formation in soft agar, and motility, all good indicators for malignant progression, of SW480 colon carcinoma cells are dramatically increased by enforced Tb-4 expression. To test the hypothesis that overexpression of this G-actin sequestering peptide also promotes tumor invasion, we examined not only the invasion capability of Tb-4-overexpressing SW480 cells, but also the expression levels of Tb-4 as well as several proteins that participate in different stages of tumor progression in matched samples of human primary colorectal adenocarcinoma and liver metastases from several patients. A marked increase on the invasiveness in Tb-4-overexpressing SW480 cells with increased levels and activity of matrix metalloproteinase-7 (MMP-7) was observed. Furthermore, the levels of Fas as well as the susceptibility to Fas ligand-mediated apoptosis in Tb-4-overexpressing cells were significantly decreased. Interestingly, the levels of Tb-4 mRNA, b-catenin, c-Myc, and MMP-7 in metastatic liver lesions were relatively higher, whereas the levels of E-cadherin and Fas were significantly lower than those in the matched primary colorectal tumors. These results suggest that upregulation of Tb-4, by promoting the disruption of cell-cell adhesion and a consequential activation of the b-catenin signaling, could be a key event in the acquisition of growth advantages as well as invasive phenotypes in human colorectal carcinomas.
Cell-matrix and cell-cell adhesive interactions play important roles in the normal organization and stabilization of the cell layer in epithelial tissue. Alterations in the expression and function of these adhesion systems that cause a switch to a migratory phenotype in tumor invasion and metastasis are critical for the malignant conversion of epithelial cells. Thymosin b-4 (Tb-4) is the major actinsequestering protein that has been shown to be upregulated in a wide variety of human carcinomas and has been implicated to be involved in altering the motility of certain tumors. We have recently demonstrated that the growth rate, colony formation in soft agar, and motility, all good indicators for malignant progression, of SW480 colon carcinoma cells are dramatically increased by enforced Tb-4 expression. To test the hypothesis that overexpression of this G-actin sequestering peptide also promotes tumor invasion, we examined not only the invasion capability of Tb-4-overexpressing SW480 cells, but also the expression levels of Tb-4 as well as several proteins that participate in different stages of tumor progression in matched samples of human primary colorectal adenocarcinoma and liver metastases from several patients. A marked increase on the invasiveness in Tb-4-overexpressing SW480 cells with increased levels and activity of matrix metalloproteinase-7 (MMP-7) was observed. Furthermore, the levels of Fas as well as the susceptibility to Fas ligand-mediated apoptosis in Tb-4-overexpressing cells were significantly decreased. Interestingly, the levels of Tb-4 mRNA, b-catenin, c-Myc, and MMP-7 in metastatic liver lesions were relatively higher, whereas the levels of E-cadherin and Fas were significantly lower than those in the matched primary colorectal tumors. These results suggest that upregulation of Tb-4, by promoting the disruption of cell-cell adhesion and a consequential activation of the b-catenin signaling, could be a key event in the acquisition of growth advantages as well as invasive phenotypes in human colorectal carcinomas.
Colon carcinogenesis is the result of a progressive transformation of colonic epithelial cells, which accumulates genetic as well as epigenetic changes that both increase their growth and alter their phenotypes (Fearon and Vogelstein, 1990) . A common event observed during the transition from adenoma to carcinoma which involves the acquisition of invasive capacity, is the loss of E-cadherin, a transmembrane linker protein of the adherence junctions that plays a key role in the maintenance of the adhesive and polarized phenotype of epithelial cells (Takeichi, 1995; Gumbiner, 1996) . In fact, tumor suppressive activity of E-cadherin has been demonstrated in a variety of cancers including colorectal carcinoma (CRC) (Semb and Christofori, 1998) .
In addition to supporting stable cell-cell contacts to maintain tissue cohesion, E-cadherin also functions as a sequestering protein of b-catenin, a transcriptional activator in Wnt signaling (Kikuchi, 2000) . When not being segregated by E-cadherin on the cell membrane, bcatenin is rapidly phosphorylated by glycogen synthetase kinase-3b (GSK-3b) in the adenomatous polyposis coli (APC)/axin/GSK-3b complex and is subsequently degraded by the ubiquitin-proteosome pathway (Morin, 1999) . On the other hand, accumulation of the cytosolic b-catenin and its nuclear translocation might occur if any of the genes encoding aforementioned proteins was mutated. Upon translocating into nuclei, b-catenin binds with a member of the T-cell factor (TCF)/ lymphoid enhancer factor (LEF) family of transcription factors, to form a complex that activates transcription of a number of genes whose products could modulate cell proliferation and invasion.
Immune privilege is another crucial factor for the survival and metastasis of some types of cancer (O'Connell et al., 2001) and maintenance of this effect is dependent on the collective production of a number of negative immune modulators, including Fas ligand (FasL) (Streilein, 1995) . In addition to inducing apoptosis of activated lymphocytes via interacting with its receptor (Fas/Apo-1/CD95) (Cardi et al., 1998) , FasL is capable of facilitating the establishment of tumor metastasis in tissues such as liver, because the hepatocytes are sensitive to FasL (Shiraki et al., 1997) . In contrast, colon cancer cells seem to escape from FasLmediated cytotoxicity of T, NK, lymphokine-activated killer (LAK), and FasL-bearing tumor cells by downregulating Fas (O'Connell et al., 1998) .
In a previous study, we have shown that disruption of the actin microfilaments in SW480 colon carcinoma cells by overexpressing a G-actin sequestering peptide, thymosin b-4 (Tb-4), results in a drastic change in cell growth and motility which is likely to be accounted by a deregulated cell-cell adhesion arisen from E-cadherin downregulation, plus an uncontrolled cell proliferation owing to an enhanced b-catenin signaling (Wang et al., 2003) . Although these in vitro findings suggest an important role of Tb-4 upregulation in promoting the malignant progression of colon carcinoma cells, its in vivo effects are unclear. Moreover, correlation between Tb-4 expression and the in situ distant metastasis of colon cancer has not yet been determined. In this study, we demonstrate that Tb-4 overexpression promotes the in vivo growth and invasion of SW480 cells and the latter is likely due to an activation of MMP-7 and a reduction of Fas. More importantly, we provide evidence for the first time that the loss of E-cadherin, Fas and the activation of b-catenin/TCF signaling may be the major mechanisms underlying the effects of Tb-4 upregulation in promoting liver metastasis of human CRC.
In vivo tumorigenecity of the Tb-4-overexpressing SW480 colon carcinoma cells was analysed in a tumor xenograft model. In agreement with our in vitro observations (Wang et al., 2003) , both the growth rate ( Figure 1a ) and tumor weight (Figure 1b ) of Tb-4 overexpressers (480S1 and 480S2) were significantly higher than those of the parental as well as the vectortransfected cells (480BK), demonstrating the importance of aberrant expression of this G-actin-sequestering protein in conferring in vivo growth advantages to colon cancer cells.
For a tumor to metastasize, its invasive capability must be enhanced and the extracellular proteases, especially the matrix metalloproteinases (MMPs), appear to play important roles in this process. In fact, the invasion of cancer cells into nearby stroma, across blood vessel walls, and through normal epithelial cell layers have been shown to be promoted by various MMPs (Vihinen and Kahari, 2002) . Since the levels of bcatenin, a well-known activator of MMP-7 (Brabletz et al., 1999) , was found to be augmented in the Tb-4-overexpressing SW480 cells (Wang et al., 2003) , increased MMP activities and a consequential enhanced invasion of these cells were postulated. Indeed, higher levels of MMP-7 were found in Tb-4 overexpressers ( Figure 2a ) which were accompanied by a stronger protease activity (Figure 2b ). Accordingly, a greater invasive capability of Tb-4-overexpressers was not only revealed by our in vitro assay (Figure 2c ) but also by our in vivo data, which showed a dramatic increase in the adhesion and infiltration of these cells to their adjacent skin ( Figure 2d ) and muscle tissues (Figure 2e ). Taken together, these results strongly support the notion that increased Tb-4 expression is critical for facilitating both the proliferation and invasion of colon carcinoma.
In addition to barrier clearance by MMPs, resistance to host defense mechanisms, especially the immune surveillance, is also critical for tumor cells to metastasize. In this regard, constitutive expression of FasL, a renowned apoptosis trigger, was detected in a variety of tumors (Moller et al., 1994; O'Connell et al., 1996; O'Connell et al., 2001) and FasL-mediated counterattacks by tumor were also demonstrated in a number of Figure 1 Tb-4 overexpression promotes the in vivo growth of SW480 human colon carcinoma cells. A tumor xenograft growth assay was performed using stable transfectants derived from the SW480 cells established previously by us (Wang et al., 2003) including 480S1 & 480S2 (Tb-4-overexpressing clones), 480BK (vector control), and the parental cells. After being trypsinized and washed once in PBS, cells were then resuspended in PBS at a concentration of 2 Â 10 6 cells/ml. A total of 1 Â 10 6 cells were injected subcutaneously onto the back of 8-week-old athymic nude mice (National Laboratory Animal Center, Nankang, Taiwan), and the size of the growing tumors was determined by measuring their length and width with calipers every week (a). The weight of the tumors was measured at the 7th week after the mice were killed (b). Data are means7s.d. from five independent determinations. *Po0.05 when compared with the parental and vector-transfected SW480 cells by one-way ANOVA with repeated measures carcinomas (O'Connell et al., 2000; Chopin et al., 2003) . On the other hand, downregulation of Fas, the receptor for FasL, has been postulated to be an important mechanism for cancer cells, especially colon cancer, to escape FasL-mediated immune surveillance (Houghton et al., 1997) . Interestingly, decreased Fas expression The enzymatic activity of the matrix metalloproteinases (MMPs) in different cell lines was determined by proteolytic cleavage of a fluorogenic substrate Ac-Pro-Leu-[2-mercapto-4-methyl-pentanoyl]-Leu-Gly-OC 2 H 5 (Biomol, Butler Pike, PA, USA) using total cell lysates as enzyme sources. The assays were carried out with 50 mg cell lysates in a buffer (50 mM HEPES, 10 mM CaCl 2 , 0.05% Brij-35, pH 7.0) at 301C and fluorescence was measured by a spectrofluorometer using excitation and emission wavelengths at 340 and 440 nm, respectively. The initial rates were calculated from the changes in fluorescence as described previously (Netzel-Arnett et al., 1991) using substrate concentrations of 10, 20, 30, 40, 60, 80, 100, 150 mM. Each substrate concentration was assayed three times and the kinetic curves were plotted. (c) In vitro invasion of these cells was assessed by examining their abilities to invade through the transwells coated with basement membrane Matrigel as previously described (Albini et al., 1987) . Polycarbonate filters (12 mm pore size) in the Boyden chamber (Becton Dickinson & Co., Oxford, CA, USA) were coated with 100 ml (0.95 mg of protein/ml) of Matrigel matrix (BD Bioscience, Benford, MA, USA). Single cell suspensions obtained by trypsinization were placed into the upper chamber in L-15 medium (Life Technologies, Rockville, MD, USA) containing 10% fetal calf serum at a density of 10 5 cells/well. After incubation at 371C for 24 h, cells that did not penetrate the filter were wiped off by PBS-rinsed cotton swabs, and cells that had migrated to the lower surface of the filter were stained with Hoechst33258 and counted by a fluorescence microscope (Olympus, Tokyo, Japan). Values for invasion were expressed as the average number of migrated cells per microscopic field over six fields per assay from three independent experiments. Data are means7s.d. from three independent determinations. *Po0.05 when compared with the parental and vector-transfected SW480 cells by one-way ANOVA with repeated measures. Significant increases in adhesion and infiltration of the tumor cells derived from Tb-4 overexpressers to their adjacent skin (d) and muscle (e) tissues were found in nude mice. Tumor tissue collection from killed animals was performed in the Animal Resource Center of the National Yang-Ming University. Postmortem studies including tumor sectioning, H&E staining, and microscopic examination were performed by an experienced pathologist at Taipei Veterans General Hospital. * Photographs A, B, C, and D represent cell lines SW480, 480BK, 480S1, and 480S2, respectively, with a magnification of Â 400 found in the majority of colon carcinomas (O'Connell et al., 1996 (O'Connell et al., , 2000 has recently been shown to result possibly from a b-catenin-mediated interference of NFkB activation (Deng et al., 2002) . Therefore, downregulation of Fas expression (Figure 3a) and reduced susceptibility to FasL-mediated apoptosis in the Tb-4-overexpressing SW480 cells (Figure 3b ) resulted possibly from a b-catenin-mediated inhibition of NF-kB, might help these cells to escape immune surveillance.
An upregulated expression of the genes encoding several b-thymosin family members in human cancers was well documented (Califano et al, 1998; Santelli et al., 1999; Sardi et al., 2002) and Tb-4, especially, was postulated to play critical roles in the malignant progression of a number of tumors (Clark et al., 2000; Kobayashi et al., 2002; Xie et al., 2002; Cha et al., 2003; Wang et al., 2003) . However, direct comparison of the expression of Tb-4 in the specimens of primary human colon cancers and paired liver metastases has not yet been reported. Our results showing a marked increase (five-to 10-fold) in Tb-4 mRNA levels in the liver metastases (Figure 4 ) strongly suggest a positive role played by this G-actin-sequestering protein in facilitat- 4 cells from each line were seeded in triplicate in a 96-well plate with 0.2 ml of culture medium for 24 h. An anti-Fas IgM (Upstate, Lake Placid, NY, USA), serves as a Fas ligand, was then added in a concentration of 40 ng/ml and incubated for an additional 48 h. The medium was then replaced by 0.1 ml of fresh medium containing 10 ml of MTT (5 mg/ml in PBS) (Sigma, St Louis, MO, USA). After incubation at 371C for 4 h, 0.1 ml lysis buffer (20% SDS in 50% DMF) was added and the absorbance at 570 nm was measured using a Microplate Reader (Model 550, BIO-RAD). Data are means7s.d. from three independent determinations. *Po0.05 when compared with the parental and vector-transfected SW480 cells by one-way ANOVA with repeated measures Figure 4 Levels of thymosin b-4 (Tb-4) mRNA, b-catenin, c-Myc, and MMP-7 in metastatic liver tumors were relatively higher, whereas the levels of E-cadherin and Fas were significantly lower than those of the matched primary colorectal tumors. (a) Tissue samples of the primary colorectal adenocarcinoma (T) and matched synchronous liver metastasis (M) of the same patient were obtained from eight patients undergoing surgical resection in Taipei Veterans General Hospital. All patients were thoroughly informed about the aims of the study and gave written consent for the investigation. Histopathological confirmation of the samples was performed by an experienced pathologist in Taipei Veterans General Hospital. Tumor tissues were excised from adjacent normal tissue by sharp dissection, washed in PBS and flash-frozen in liquid nitrogen. Total RNAs were then isolated from tissue samples of primary tumors and their matched metastatic liver tumors of eight CRC patients as previously described (Su et al., 2000) . A measure of 50 mg total RNAs were separated on l% formaldehyde-agarose gel and transferred onto a nitrocellulose membrane. Northern hybridization using a 32 P-labeled Tb-4 cDNA fragment as a probe was then performed as described (Su et al., 2000) . In the meantime, 50 mg of protein was separated on a 10% SDS-polyacrylamide gel and processed for immunoblotting with anti-E-cadherin (BD), anti-b-catenin (Sigma), anti-c-Myc (BD), anti-MMP-7 (Santa Cruz), and anti-Fas (Santa Cruz) antibodies, and developed using enhanced chemiluminescence (NEN Life Science, Boston, MA, USA). Each blot was subsequently reprobed with an anti-b-tubulin (BD) monoclonal antibody to confirm equal loading of each sample. (b) In order to clarify the mean metastatic lesion (M)-to-primary tumor (T) ratio of Tb-4 mRNA as well as the above-mentioned proteins that involved in cancer metastasis, the levels of these molecules were quantified by measuring the intensities of the appropriate bands using a laser densitometer. Data are means7s.d. from eight independent determinations ing distant metastasis of CRC. Interestingly, a drastic reduction in E-cadherin levels was also found in the liver metastases (Figure 4) , which is in good agreement with our previous observations (Wang et al., 2003) . Decreased E-cadherin correlates with de-differentiation, infiltrative tumor growth and metastasis. Moreover, reduced E-cadherin expression at the intercellular junctions was reported to correlate significantly with higher tumor grading and poor prognosis of patients in some instances (Birchmeier and Behrens, 1994; Bracke et al., 1996) . An internalization and intracellular degradation of this cell adhesion molecule Marambaud et al., 2002) owing to the disruption of adhesion complex triggered by Tb-4-induced breakdown of the actin cytoskeleton (Wang et al., 2003) , or a cell surface cleavage of E-cadherin by MMP-7 (Noe et al., 2001) , or a combination of both was speculated. Further studies are required to distinguish between these possibilities.
Loss of E-cadherin has been hypothesized to cause the accumulation of b-catenin free to bind TCF/LEF and to modulate transcription (Semb and Christofori, 1998) . Among proteins encoded by these genes, c-Myc and cyclin D1 are well-known growth-promoting factors, whereas matrix metalloproteinase-7 (MMP-7) is a mediator for stromal invasion (Wong and Pignatelli, 2002 ). In the current study, an inverse correlation between the levels of E-cadherin and b-catenin (Figure 4) , as well as a positive correlation between increased b-catenin and c-Myc activation (Figure 4) found in the clinical specimens, strongly support the notion that activation of the b-catenin signaling is crucial for the acquisition of growth advantage(s) by tumor cells during metastasis. Therefore, upregulated Tb-4 expression, by disrupting the actin filaments, might promote the release of b-catenin from cell membrane, which in turn could form transcriptional complex with TCF-4 and activates its downstream target genes, through which to facilitate tumor invasion and metastasis.
To invade other tissues, tumors often generate a number of MMPs and some of them were found to have a positive correlation with CRC metastasis (Mori et al., 1995; Ishikawa et al., 1996; Adachi et al., 2001; Zeng et al., 2002; Yamamoto et al., 2003) . Among these proteases, MMP-7 is best known for its involvement in the malignant progression of CRC (Mori et al., 1995; Ishikawa et al., 1996) , especially in liver metastasis (Adachi et al., 2001; Zeng et al., 2002) . In fact, the worst prognosis has been reported in CRC patients with overexpressed MMP-7 and trypsin at the invasive front of tumors (Yamamoto et al., 2003) . Our result showing a dramatic increase in MMP-7 expression in CRC liver metastases (Figure 4 ) strongly supports the involvement of this protease in promoting the invasion/metastasis of colon cancer. Finally, a significant decrease in Fas expression observed in the metastatic samples (Figure 4) , suggests that abrogation of the Fas/FasL signaling pathway might also be crucial for distant metastasis of human CRC.
In summary, we have shown for the first time that Tb-4 overexpression is tightly associated with increased invasion of SW480 colon carcinoma cells as well as distant metastasis of human CRC. Overexpression of this G-actin-binding protein results in a downregulation of E-cadherin possibly through a disruption of actin cytoskeleton, which may lead to a reduction or loss of cell-cell interactions and a consequential detachment of malignant cells from the primary tumor. Meanwhile, upregulated b-catenin stimulates the expression of cMyc and MMP-7 which may in turn confer the growth and invasion/metastasis advantages, respectively, to tumor cells. Finally, downregulation of Fas expression in the metastatic tumor samples might represent another advantage, such as immune privilege, for CRC metastasis. Taken together, these results warrant an elucidation of the mechanism underlying metastasis-associated upregulation of Tb-4 expression for designing a better approach for CRC treatment. Experiments of this nature are currently underway in our laboratory.
